Pakistanis angry over detentions in Times Sq. case Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They
AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e
BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German
Minister seeks closure of anti-Berlusconi websites Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who
By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an
Navigation
Primary Navigation
Home
Singapore
Asia Pacific
World
Business
Entertainment
Sports
Technology
Top Stories
Most Popular
Secondary Navigation
Search
Search:
Pfizer to acquire rival Wyeth for $68 bln
AFP - 2 hours 17 minutes ago
NEW YORK (AFP) - - US drug manufacturer Pfizer Inc. will acquire rival Wyeth for 68 billion dollars, making it the largest pharmaceutical takeover deal in nearly a decade, the two companies announced early Monday.
A consortium of banks has agreed to provide a total of 22.5 billion dollars to finance the deal.
Under the terms of the cash-and-stock transaction, each outstanding share of Wyeth common stock will be converted into a shareholder right to receive 33 in cash and 0.985 of a share of Pfizer common stock.
The acquisition will be financed through a combination of cash, debt and stock.
The boards of directors of both companies have approved the merger.
"The combination of Pfizer and Wyeth provides a powerful opportunity to transform our industry," Jeffrey Kindler, chairman and chief executive officer of Pfizer said in a staement.
"It will produce the world's premier biopharmaceutical company whose distinct blend of diversification, flexibility, and scale positions it for success in a dynamic global health care environment."
Wyeth president an CEO Bernard Poussot said that combining with Pfizer will accelerate the company's "pursuit of innovative new medicines to meet critical unmet patient needs."
The deal appears to be the largest takeover in the pharmaceutical sector since Pfizer acquired Warner-Lambert Co. for 93.4 billion dollars in 2000.
Participants said the new company will have more resources to invest in research and development than any other biopharmaceutical company and access to all leading scientific technology platforms, including vaccines, small and large molecules, nutritionals and consumer products.
According to The Wall Street Journal, Pousso and his management team are not expected to remain with the company after the takeover.
Email Story
IM Story
Printable View
Blog This
Recommend this article
Average (1 vote)
Sign in to recommend this article »
Most Recommended Stories »
Enlarge Photo
US drug manufacturer Pfizer Inc. will acquire rival Wyeth for 68 billion dollars, making it the largest pharmaceutical takeover deal in nearly a decade
Most Popular – Top Stories
Viewed
Child matador kills six bulls in Mexico
Hudson 'miracle' pilot gets hero's homecoming
Global warming could unleash ocean 'dead zones': study
'Dogs don't wear condoms,' says Baywatch star Anderson
Ring of fire: Indian Ocean to see solar eclipse
View Complete List »
Search:
Home
Singapore
Asia Pacific
World
Business
Entertainment
Sports
Technology
Top Stories
Most Popular